Department of Chemistry, The George Washington University, Washington, DC, 20052, USA.
Research Center for Genetic Medicine, Children's National Medical Center, Washington, DC, 20010, USA.
J Mass Spectrom. 2020 Apr;55(4):e4443. doi: 10.1002/jms.4443. Epub 2019 Dec 2.
Mass spectrometry imaging (MSI) is used increasingly to simultaneously detect a broad range of biomolecules while mapping their spatial distributions within biological tissue sections. Matrix-assisted laser desorption ionization (MALDI) is recognized as the method-of-choice for MSI applications due in part to its broad molecular coverage. In spite of the remarkable advantages offered by MALDI, imaging of neutral lipids, such as triglycerides (TGs), from tissue has remained a significant challenge due to ion suppression of TGs by phospholipids, e.g. phosphatidylcholines (PCs). To help overcome this limitation, silicon nanopost array (NAPA) substrates were introduced to selectively ionize TGs from biological tissue sections. This matrix-free laser desorption ionization (LDI) platform was previously shown to provide enhanced ionization of certain lipid classes, such as hexosylceramides (HexCers) and phosphatidylethanolamines (PEs) from mouse brain tissue. In this work, we present NAPA as an MSI platform offering enhanced ionization efficiency for TGs from biological tissues relative to MALDI, allowing it to serve as a complement to MALDI-MSI. Analysis of a standard lipid mixture containing PC(18:1/18:1) and TG(16:0/16:0/16:0) by LDI from NAPA provided an ~49 and ~227-fold higher signal for TG(16:0/16:0/16:0) relative to MALDI, when analyzed without and with the addition of a sodium acetate, respectively. In contrast, MALDI provided an ~757 and ~295-fold higher signal for PC(18:1/18:1) compared with NAPA, without and with additional Na . Averaged signal intensities for TGs from MSI of mouse lung and human skin tissues exhibited an ~105 and ~49-fold increase, respectively, with LDI from NAPA compared with MALDI. With respect to PCs, MALDI provided an ~2 and ~19-fold increase in signal intensity for mouse lung and human skin tissues, respectively, when compared with NAPA. The complementary coverage obtained by the two platforms demonstrates the utility of using both techniques to maximize the information obtained from lipid MS or MSI experiments.
质谱成像(MSI)越来越多地用于同时检测广泛的生物分子,同时绘制它们在生物组织切片中的空间分布。基质辅助激光解吸电离(MALDI)被认为是 MSI 应用的首选方法,部分原因是它具有广泛的分子覆盖范围。尽管 MALDI 提供了显著的优势,但由于磷脂(例如磷脂酰胆碱(PCs))对甘油三酯(TGs)的离子抑制,组织中中性脂质(如甘油三酯(TGs))的成像仍然是一个重大挑战。为了帮助克服这一限制,引入了硅纳米柱阵列(NAPA)基底,以从生物组织切片中选择性地离子化 TGs。这种无基质的激光解吸电离(LDI)平台之前已被证明可以增强某些脂质类别的电离,例如来自小鼠脑组织的己糖神经酰胺(HexCers)和磷脂酰乙醇胺(PEs)。在这项工作中,我们将 NAPA 作为一种 MSI 平台展示,与 MALDI 相比,它提供了从生物组织中 TGs 的增强电离效率,使其可以作为 MALDI-MSI 的补充。通过 LDI 从 NAPA 分析包含 PC(18:1/18:1)和 TG(16:0/16:0/16:0)的标准脂质混合物时,与 MALDI 相比,当分别分析而不添加和添加醋酸钠时,TG(16:0/16:0/16:0)的信号分别提高了约 49 和 227 倍。相比之下,MALDI 提供的 PC(18:1/18:1)信号分别比 NAPA 高约 757 和 295 倍,而无需添加额外的 Na。与 MALDI 相比,通过 NAPA 从 MSI 的小鼠肺和人皮肤组织中的 TGs 的平均信号强度分别增加了约 105 和 49 倍。就 PCs 而言,与 NAPA 相比,MALDI 分别为小鼠肺和人皮肤组织提供的信号强度增加了约 2 和 19 倍。两种平台获得的互补覆盖范围证明了使用这两种技术来最大限度地从脂质 MS 或 MSI 实验中获取信息的实用性。